Table 2.
Efficacy (mean AL change) and acceptability (dropout rate) in each study at 2-year follow-up.
| Mean AL change (mm) | Dropout rate (dropouts/total) | |||
|---|---|---|---|---|
| Treatment group | Control group | Treatment group | Control group | |
| Cho et al. [16] | 0.29 ± 0.27 | 0.54 ± 0.27 | 8/43 | NA |
| Walline et al. [17] | 0.25 ± 0.27a | 0.57 ± 0.40a | 12/40 | NA |
| Kakita et al. [18] | 0.39 ± 0.27 | 0.61 ± 0.24 | 3/45 | 10/60 |
| Cho and Cheung [19] | 0.36 ± 0.24 | 0.63 ± 0.26 | 14/51 | 10/51 |
| Hiraoka et al. [20] | 0.45 ± 0.21 | 0.71 ± 0.40 | 7/29 | 9/30 |
| Santodomingo-Rubido et al. [21, 24] | 0.47 ± 0.20b | 0.69 ± 0.30b | 2/31 | 6/30 |
| Charm and Cho [22] | 0.19 ± 0.21 | 0.51 ± 0.32 | 14/26 | 10/26 |
| Chen et al. [23] | 0.31 ± 0.27 | 0.64 ± 0.31 | 8/43 | 14/37 |
AL = axial length; NA = not available.
a used the highest sd value of other studies with the same follow-up period.
b derived from standard error in combination with GetData Graph Digitizer 2.24 (http://getdata-graph-digitizer.com/).